ASX - By Stock
|
NOX |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
darcher
|
2 |
1.2K |
1 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
2
|
1.2K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
LUPIN again
|
|
darcher
|
5 |
2K |
0 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
5
|
2K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: DARRT-2 Trial Efficacy Phase to Commence
|
|
darcher
|
14 |
4.9K |
0 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
14
|
4.9K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4E and Audited Financial Statements
|
|
darcher
|
39 |
11K |
1 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
39
|
11K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4E and Audited Financial Statements
|
|
darcher
|
39 |
11K |
0 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
39
|
11K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: DARRT-2 Trial Safety Milestone and European Site Activated
|
|
darcher
|
7 |
2.8K |
1 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
7
|
2.8K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Are we expecting any news from NOX in near future?
|
|
darcher
|
72 |
23K |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
72
|
23K
|
0
|
|
ASX - By Stock
|
NYR |
Re:
Ann: NYX-PCSK9i In Vivo Study Exploratory Analysis Results
|
|
darcher
|
74 |
25K |
2 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
74
|
25K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: September 2021 Quarterly Activities Report and Appendix 4C
|
|
darcher
|
16 |
4.0K |
0 |
14/10/21 |
14/10/21 |
ASX - By Stock
|
16
|
4.0K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
IONIC
|
|
darcher
|
14 |
4.5K |
1 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
14
|
4.5K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: NOXCOVID Program to Expand After Positive Phase 1 Results
|
|
darcher
|
49 |
13K |
1 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
49
|
13K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: NOXCOVID Program to Expand After Positive Phase 1 Results
|
|
darcher
|
49 |
13K |
0 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
49
|
13K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: DARRT-2 Study Update and Clarification
|
|
darcher
|
21 |
5.9K |
8 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
21
|
5.9K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Perspective
|
|
darcher
|
5 |
1.4K |
2 |
01/06/21 |
01/06/21 |
ASX - By Stock
|
5
|
1.4K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Patent update
|
|
darcher
|
16 |
6.1K |
2 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
16
|
6.1K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Pause in Trading
|
|
darcher
|
17 |
5.7K |
0 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
17
|
5.7K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Pause in Trading
|
|
darcher
|
17 |
5.7K |
0 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
17
|
5.7K
|
0
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Trading Halt
|
|
darcher
|
16 |
4.7K |
2 |
21/03/21 |
21/03/21 |
ASX - By Stock
|
16
|
4.7K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Option Underwriting Agreement to Secure Funds
|
|
darcher
|
22 |
6.8K |
0 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
22
|
6.8K
|
0
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Investor Presentation to Finance News Network CEO Showcase
|
|
darcher
|
11 |
4.4K |
0 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
11
|
4.4K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
CEO LuPIN Blog
|
|
darcher
|
2 |
931 |
3 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
2
|
931
|
3
|
|
ASX - By Stock
|
NYR |
Re:
News: NYR Nyrada Secures Collaboration With Walter Reed And UNSW
|
|
darcher
|
1 |
403 |
5 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
1
|
403
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Webinar Observations
|
|
darcher
|
14 |
5.0K |
3 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
14
|
5.0K
|
3
|
|
ASX - By Stock
|
TTM |
Re:
Ann: Jerusalem Gold Project Concession in Ecuador Reinstated
|
|
darcher
|
393 |
67K |
0 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
393
|
67K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Appoints US Corporate Advisory and Consulting Firm
|
|
darcher
|
8 |
3.3K |
2 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
8
|
3.3K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Appoints US Corporate Advisory and Consulting Firm
|
|
darcher
|
8 |
3.3K |
2 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
8
|
3.3K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Veyonda COVID-19 Study Approved For Immediate Start
|
|
darcher
|
6 |
2.5K |
1 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
6
|
2.5K
|
1
|
|
ASX - By Stock
|
NYR |
Re:
capital raising
|
|
darcher
|
3 |
1.3K |
1 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Nyrada Cholesterol-Lowering Drug Study Results
|
|
darcher
|
54 |
13K |
2 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
54
|
13K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Ceasing to be a substantial holder
|
|
darcher
|
4 |
2.1K |
0 |
04/07/20 |
04/07/20 |
ASX - By Stock
|
4
|
2.1K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Despatch of Pro Rata Entitlement Offer Documents
|
|
darcher
|
4 |
2.3K |
0 |
22/05/20 |
22/05/20 |
ASX - By Stock
|
4
|
2.3K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Investigating Potential COVID-19 Treatment
|
|
darcher
|
34 |
18K |
2 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
34
|
18K
|
2
|
|
ASX - By Stock
|
SKN |
Re:
Ann: Suspension from Official Quotation
|
|
darcher
|
59 |
12K |
3 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
59
|
12K
|
3
|
|
ASX - By Stock
|
NYR |
Re:
IPO - Nyrada Inc.
|
|
darcher
|
137 |
95K |
2 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
137
|
95K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Lodgement of Nyrada Inc Prospectus - Initial Public Offering
|
|
darcher
|
6 |
8.6K |
1 |
26/11/19 |
26/11/19 |
ASX - By Stock
|
6
|
8.6K
|
1
|
|
ASX - By Stock
|
TTM |
Titan
|
|
darcher
|
2 |
2.1K |
1 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
2
|
2.1K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm August 2019 Corporate Presentation
|
|
darcher
|
12 |
5.8K |
0 |
07/08/19 |
07/08/19 |
ASX - By Stock
|
12
|
5.8K
|
0
|
|
ASX - By Stock
|
TTM |
Re:
Ann: Appointment and Resignation of Members to the Board
|
|
darcher
|
46 |
13K |
1 |
27/07/19 |
27/07/19 |
ASX - By Stock
|
46
|
13K
|
1
|
|
ASX - By Stock
|
TTM |
Re:
Ann: Appointment and Resignation of Members to the Board
|
|
darcher
|
46 |
13K |
0 |
26/07/19 |
26/07/19 |
ASX - By Stock
|
46
|
13K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Mergers and Acquisitions
|
|
darcher
|
30 |
12K |
3 |
16/07/19 |
16/07/19 |
ASX - By Stock
|
30
|
12K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Mergers and Acquisitions
|
|
darcher
|
30 |
12K |
3 |
15/07/19 |
15/07/19 |
ASX - By Stock
|
30
|
12K
|
3
|
|
ASX - By Stock
|
TTM |
Re:
Ann: Results of Core Gold Meeting and Response to Allegations
|
|
darcher
|
25 |
7.4K |
1 |
18/06/19 |
18/06/19 |
ASX - By Stock
|
25
|
7.4K
|
1
|
|
ASX - By Stock
|
TTM |
Re:
Ann: Results of Core Gold Meeting and Response to Allegations
|
|
darcher
|
25 |
7.4K |
1 |
18/06/19 |
18/06/19 |
ASX - By Stock
|
25
|
7.4K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Change in Noxopharm Limited Board Structure
|
|
darcher
|
9 |
4.7K |
4 |
24/04/19 |
24/04/19 |
ASX - By Stock
|
9
|
4.7K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: KZA: Kazia sells stake in Noxopharm
|
|
darcher
|
7 |
10K |
1 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
7
|
10K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Annual Report to shareholders
|
|
darcher
|
8 |
4.6K |
1 |
27/09/18 |
27/09/18 |
ASX - By Stock
|
8
|
4.6K
|
1
|
|
ASX - By Stock
|
TTM |
Re:
Ann: Public Offer Update
|
|
darcher
|
13 |
4.4K |
0 |
28/09/17 |
28/09/17 |
ASX - By Stock
|
13
|
4.4K
|
0
|
|
ASX - By Stock
|
TTM |
Re:
best consolidation ratio on ASX
|
|
darcher
|
32 |
13K |
6 |
17/05/17 |
17/05/17 |
ASX - By Stock
|
32
|
13K
|
6
|
|
ASX - By Stock
|
TTM |
Re:
best consolidation ratio on ASX
|
|
darcher
|
32 |
13K |
2 |
11/05/17 |
11/05/17 |
ASX - By Stock
|
32
|
13K
|
2
|
|
ASX - By Stock
|
TTM |
Re:
Ann: Update on Deed of Company Arrangement
|
|
darcher
|
26 |
7.6K |
0 |
28/03/17 |
28/03/17 |
ASX - By Stock
|
26
|
7.6K
|
0
|
|